JP2012070736A5 - - Google Patents

Download PDF

Info

Publication number
JP2012070736A5
JP2012070736A5 JP2011224456A JP2011224456A JP2012070736A5 JP 2012070736 A5 JP2012070736 A5 JP 2012070736A5 JP 2011224456 A JP2011224456 A JP 2011224456A JP 2011224456 A JP2011224456 A JP 2011224456A JP 2012070736 A5 JP2012070736 A5 JP 2012070736A5
Authority
JP
Japan
Prior art keywords
sequence
pkd1 gene
region
primer
region comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011224456A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012070736A (ja
JP5536005B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2012070736A publication Critical patent/JP2012070736A/ja
Publication of JP2012070736A5 publication Critical patent/JP2012070736A5/ja
Application granted granted Critical
Publication of JP5536005B2 publication Critical patent/JP5536005B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2011224456A 2000-07-13 2011-10-12 多発性嚢胞腎疾患の検出と治療 Expired - Fee Related JP5536005B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21826100P 2000-07-13 2000-07-13
US60/218,261 2000-07-13
US28369101P 2001-04-13 2001-04-13
US60/283,691 2001-04-13

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2002512419A Division JP2004504038A (ja) 2000-07-13 2001-07-13 多発性嚢胞腎疾患の検出と治療

Publications (3)

Publication Number Publication Date
JP2012070736A JP2012070736A (ja) 2012-04-12
JP2012070736A5 true JP2012070736A5 (enExample) 2012-12-27
JP5536005B2 JP5536005B2 (ja) 2014-07-02

Family

ID=26912733

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002512419A Pending JP2004504038A (ja) 2000-07-13 2001-07-13 多発性嚢胞腎疾患の検出と治療
JP2011224456A Expired - Fee Related JP5536005B2 (ja) 2000-07-13 2011-10-12 多発性嚢胞腎疾患の検出と治療

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2002512419A Pending JP2004504038A (ja) 2000-07-13 2001-07-13 多発性嚢胞腎疾患の検出と治療

Country Status (5)

Country Link
US (4) US7553644B2 (enExample)
JP (2) JP2004504038A (enExample)
AU (1) AU2001271998A1 (enExample)
CA (2) CA2395781C (enExample)
WO (1) WO2002006529A2 (enExample)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001271998A1 (en) * 2000-07-13 2002-01-30 The Johns Hopkins University School Of Medicine Detection and treatment of polycystic kidney disease
US7273701B2 (en) * 2001-10-12 2007-09-25 Athena Diagnostics, Inc. Compositions and methods for genetic analysis of polycystic kidney disease
US6916619B2 (en) 2001-10-12 2005-07-12 Athena Diagnostics, Inc. Compositions and methods for genetic analysis of polycystic kidney disease
GB0215509D0 (en) * 2002-07-04 2002-08-14 Novartis Ag Marker genes
US20050090001A1 (en) 2003-10-07 2005-04-28 Parker Stephen H. Cell lines and methods for producing proteins
US7141376B2 (en) * 2004-05-28 2006-11-28 Lyons Leslie A Carrier tests for polycystic kidney disease in the cat
GB0523659D0 (en) * 2005-11-21 2005-12-28 Novartis Ag Organic compounds
CA2993381C (en) 2006-07-24 2020-07-14 Athena Diagnostics, Inc. Method of detecting the occurrence of adpkd based on presence of nucleotide sequence alteration in pkd1
EP2142498A2 (en) * 2007-04-02 2010-01-13 Institute for Oneworld Health Cftr inhibitor compounds and uses thereof
US20090270398A1 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Pyridazine Derivatives
EP2278879B1 (en) 2008-04-21 2016-06-15 PATH Drug Solutions Compounds, compositions and methods comprising oxadiazole derivatives
US8236838B2 (en) * 2008-04-21 2012-08-07 Institute For Oneworld Health Compounds, compositions and methods comprising isoxazole derivatives
WO2009131958A2 (en) * 2008-04-21 2009-10-29 Institute For Oneworld Health Compounds, compositions and methods comprising triazine derivatives
JP2012503005A (ja) * 2008-09-19 2012-02-02 インスティテュート フォア ワンワールド ヘルス イミダゾール誘導体およびトリアゾール誘導体を含む、化合物、組成物ならびに方法。
US8511216B2 (en) * 2009-03-30 2013-08-20 Kanzaki Kokyukoki Mfg. Co., Ltd. Hydraulic actuator unit
US8343976B2 (en) * 2009-04-20 2013-01-01 Institute For Oneworld Health Compounds, compositions and methods comprising pyrazole derivatives
US20130225443A1 (en) 2010-11-05 2013-08-29 Kyoto University Method of examining polycystic kidney disease and method of screening for therapeutic agent of the disease
JP5717128B2 (ja) * 2010-11-24 2015-05-13 国立大学法人東北大学 染色体優性多発性嚢胞腎の判定方法及び予防・治療薬のスクリーニング方法
WO2013019169A1 (en) 2011-08-01 2013-02-07 Institute For Oneworld Health Phosphate prodrugs
GB201410693D0 (en) 2014-06-16 2014-07-30 Univ Southampton Splicing modulation
ES2898435T3 (es) * 2014-09-03 2022-03-07 Otsuka Pharma Co Ltd Dispositivo de ayuda para la determinación de patología, método, programa y medio de almacenamiento
CN107109411B (zh) 2014-10-03 2022-07-01 冷泉港实验室 核基因输出的定向增加
US10538812B2 (en) 2014-11-19 2020-01-21 Otsuka Pharmaceutical Co., Ltd. Primer set and method for amplifying exons of PKD1 gene and PKD2 gene
US10456404B2 (en) 2015-03-13 2019-10-29 Indiana University Research And Technology Corporation Targeting cGMP-related phosphodiesterases to reduce cyst formation in cystic kidney disease, and related materials and methods
CN104975081B (zh) * 2015-06-01 2019-03-01 南京市妇幼保健院 检测pkd1基因突变的扩增引物、试剂盒及其检测方法
CN108603230A (zh) 2015-10-09 2018-09-28 南安普敦大学 基因表达的调节与蛋白质表达失调的筛选
US11096956B2 (en) 2015-12-14 2021-08-24 Stoke Therapeutics, Inc. Antisense oligomers and uses thereof
CN116059236A (zh) 2015-12-14 2023-05-05 冷泉港实验室 用于治疗常染色体显性精神发育迟滞5型和Dravet综合征的反义寡聚体
CN106995851B (zh) * 2017-04-25 2020-07-03 郑州大学第一附属医院 扩增pkd1外显子超长片段的pcr引物、检测pkd1基因突变的试剂盒及应用
KR20260009385A (ko) 2017-08-25 2026-01-19 스톡 테라퓨틱스, 인크. 병태 및 질환 치료용 안티센스 올리고머
DE102018103215B3 (de) 2018-02-13 2019-08-14 Gna Biosolutions Gmbh Verfahren und Vorrichtung zur Extraktion einer Nukleinsäure aus einer Probenflüssigkeit
JP2021523227A (ja) 2018-05-04 2021-09-02 ストーク セラピューティクス，インク． コレステリルエステル蓄積症の処置のための方法及び組成物
KR20210134003A (ko) 2019-02-27 2021-11-08 스톡 테라퓨틱스, 인크. 병태 및 질환의 치료를 위한 안티센스 올리고머
US12338437B2 (en) 2020-05-11 2025-06-24 Stoke Therapeutics, Inc. OPA1 antisense oligomers for treatment of conditions and diseases
WO2022155435A1 (en) * 2021-01-14 2022-07-21 Mayo Foundation For Medical Education And Research Treating diseases and improving nucleic acid delivery
CN119546758A (zh) * 2022-05-25 2025-02-28 耶鲁大学 治疗、改善和/或预防多囊肾病和多囊肝病的方法
CN116179683B (zh) * 2022-12-29 2025-02-28 阅尔基因技术（苏州）有限公司 一种检测人类pkd1基因变异的探针和引物组合物及其应用
WO2024259175A2 (en) * 2023-06-13 2024-12-19 Nephrogen Inc. Systems, methods, and compositions for de-repressing pkd1
CN116732168B (zh) * 2023-08-04 2023-11-03 北京贝瑞和康生物技术有限公司 检测常染色体显性多囊肾多种突变的方法和试剂盒
CN117143997B (zh) * 2023-10-31 2024-02-23 北京中仪康卫医疗器械有限公司 一种用于pkd1基因突变检测的引物组、试剂盒及检测方法
CN118745460B (zh) * 2024-08-05 2025-07-11 英科新创（苏州）生物科技有限公司 猫pkd1基因突变位点的应用及试剂和诊断试剂盒

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
ATE267877T1 (de) * 1993-01-07 2004-06-15 Sequenom Inc Dns - sequenzierung durch massenspektronomie
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5472672A (en) * 1993-10-22 1995-12-05 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and method for polymer synthesis using arrays
EP0733110A1 (en) 1993-12-24 1996-09-25 University of Wales College of Medicine Tuberous sclerosis 2 gene and uses thereof
US5654170A (en) * 1994-10-12 1997-08-05 Johns Hopkins University Polycystic kidney disease gene
US6867288B1 (en) * 1994-10-12 2005-03-15 Genzyme Corporation Polycystic kidney disease gene
US6071717A (en) 1995-01-31 2000-06-06 Genzyme Corporation Polycystic kidney disease gene and protein
US6448389B1 (en) * 1996-04-23 2002-09-10 The Wistar Institute Of Anatomy And Biology Human cytomegalovirus DNA constructs and uses therefor
US6031088A (en) 1996-05-23 2000-02-29 Albert Einstein College Of Medicine Of Yeshiva University Polycystic kidney disease PKD2 gene and uses thereof
EP0918855A1 (en) * 1996-05-24 1999-06-02 Genzyme Corporation Polycystic kidney disease gene
EP0966719A1 (en) * 1997-03-13 1999-12-29 Opinion Corporation First Disease management system
US6297010B1 (en) * 1998-01-30 2001-10-02 Genzyme Corporation Method for detecting and identifying mutations
US6362326B1 (en) * 1998-12-22 2002-03-26 Smithkline Beecham Corporation 11 cby genomic sequence
IT1304060B1 (it) * 1998-12-29 2001-03-07 St Microelectronics Srl Variatore di livello per circuiteria a tensione d'alimentazionemultipla
AU2001271998A1 (en) * 2000-07-13 2002-01-30 The Johns Hopkins University School Of Medicine Detection and treatment of polycystic kidney disease

Similar Documents

Publication Publication Date Title
JP2011155981A5 (enExample)
JP2010227108A5 (enExample)
JP2016526529A5 (enExample)
JP2016525888A5 (enExample)
JP2013510581A5 (enExample)
WO2014191359A9 (en) Aptamers and use of the aptamers in the diagnosis and treatment of cancer
IL284578A (en) Double-stranded RNA suppressors of the hepatitis B virus, preparations containing them and their uses
JP2016528887A5 (enExample)
WO2016057951A3 (en) Crispr oligonucleotides and gene editing
JP2011177189A5 (enExample)
JP2009504138A5 (enExample)
MX356792B (es) Elementos de regulacion de plantas y sus usos.
JP2010088434A5 (enExample)
MY154507A (en) Gene Controlling Shell Phenotype in Palm
WO2010120508A3 (en) Regulation of mir-33 micrornas in the treatment of cholesterol-related disorders
EP3626830A4 (en) SINGLE NUCLEOTIDE POLYMORPHISM OF AN APOE PROMOTER RELATED TO ALZHEIMER'S MORBUS AND USE OF IT
WO2013030176A3 (en) Live attenuated influenza virus
JP2010265269A5 (enExample)
JP2016516394A5 (enExample)
JP2018534946A5 (enExample)
JP2014532403A5 (enExample)
WO2011153344A3 (en) Engineering complex microbial phenotypes with transcription enhancement
JP2014522243A5 (enExample)
NZ602137A (en) Uv associated mtdna fusion transcripts and methods and uses thereof
WO2013004396A3 (en) Adeno-parvovirus chimera with enhanced oncolytical potential